David Evans

Functions as a College/University

Offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization

Develops and commercializes new technology for RNA oligonucleotide synthesis

Develops novel targeted therapeutics for critical human diseases

Frederick National Laboratory for Cancer Research operates as a federally funded biomedical research institution dedicated to advancing understanding and treatment of cancer, AIDS, and infectious diseases. Frederick National Laboratory provides technical services such as HIV/SIV testing, HPV genotyping, antibody characterization, and nanomedicine studies, and offers training and educational modules to enhance research capacity. The company is based in Frederick. The laboratory offers specialized research programs and cores in areas such as basic science, cancer research technology, vaccine and immunity, molecular immunology, retroviral pathogenesis, bioinformatics, computational science, and clinical research. It integrates fundamental, translational, and clinical research with advanced technological capabilities including molecular diagnostics, nanotechnology characterization, cryo-electron microscopy, and multi-modality small animal imaging. The laboratory supports innovation through initiatives like the RAS Initiative and the Center for Innovation and Strategic Partnerships, fostering technology development, patents, and collaborations. Its bioinformatics directorate leverages artificial intelligence, machine learning, and advanced computing to analyze genomics, proteomics, and imaging data, supporting nationwide biomedical research efforts. The American company is ultimately controlled by the Government of the United States of America.

Develops nucleic acid drugs

Develops therapeutics for treatment of cancer and fibrosis diseases